In response to criticism Amgen appears to have greatly tightened its corporate privacy policy regarding patient information. The company has published a “privacy pledge” to US patients” and says that it will soon modify the authorization agreements that required patients participating in the company’s drug copay programs to surrender rights to their personal and health information. The move…
Amgen Requires Patients in Repatha Copay Program To Surrender Their Privacy
October 22, 2015 by 3 Comments
(This story was updated on October 23 with a statement from Amgen. It was again updated on October 27 with new information about Amgen’s patient privacy policy for a second drug, Enbrel.) (For an important followup to this story please see: Amgen Takes The Pledge To Respect Patient Privacy) The tumult over the new cholesterol…
NY Times: FDA Officials Spied On Its Own Scientists
July 14, 2012 by 5 Comments
FDA officials developed “a wide-ranging surveillance operation” against a group of its own “dissident” scientists, according to a news report by Eric Lichtblau and Scott Shane in the New York Times. The surveillance program secretly recorded thousands of emails the scientists sent to each other as well as to members of congress, journalists, and, the…
Recent Comments